Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith C Ferdinand

Showing results (31-40 of 287) with videos related to

Pageof 29
Sort By:
Journal of the Cardiometabolic Syndrome|August 7, 2007
Hypertension and the cardiometabolic syndrome--is it the blood pressure lowering or the blood pressure medication that is important?Keith C Ferdinand
Journal of Clinical Hypertension (Greenwich, Conn.)|January 15, 2016
Revealing Masked Hypertension in People of African Ancestry: We Need to Do BetterKeith C Ferdinand
Journal of the American College of Cardiology|April 27, 2019
Primordial Prevention of Cardiovascular Disease in Childhood: The Time Is NowKeith C Ferdinand
The Journal of the American Osteopathic Association|May 11, 2010
Achieving treatment goals in low-risk, asymptomatic patientsKeith C Ferdinand
Postgraduate Medicine|August 12, 2009
From protocol to practice: translating the clinical data into clinical practiceKeith C Ferdinand
Obesity (Silver Spring, Md.)|August 5, 2020
Understanding African American COVID-19 Severity and Mortality: Is Obesity the Key?Keith C Ferdinand
Journal of Clinical Hypertension (Greenwich, Conn.)|September 20, 2020
Uncontrolled hypertension in sub-Saharan Africa: Now is the time to address a looming crisisKeith C Ferdinand
Journal of Clinical Hypertension (Greenwich, Conn.)|March 9, 2006
The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?Keith C Ferdinand
Ethnicity & Disease|February 22, 2005
Retrospective analysis: consensus statement of the hypertension in African Americans working group of the International Society on Hypertension in Blacks (ISHIB)Keith C Ferdinand
Cardiorenal Medicine|February 6, 2013
Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination TherapyKeith C Ferdinand
Pageof 29

Showing results (31-40 of 287) with videos related to

Sort By:
Pageof 29
Journal of the Cardiometabolic Syndrome|August 7, 2007
Hypertension and the cardiometabolic syndrome--is it the blood pressure lowering or the blood pressure medication that is important?Keith C Ferdinand
Journal of Clinical Hypertension (Greenwich, Conn.)|January 15, 2016
Revealing Masked Hypertension in People of African Ancestry: We Need to Do BetterKeith C Ferdinand
Journal of the American College of Cardiology|April 27, 2019
Primordial Prevention of Cardiovascular Disease in Childhood: The Time Is NowKeith C Ferdinand
The Journal of the American Osteopathic Association|May 11, 2010
Achieving treatment goals in low-risk, asymptomatic patientsKeith C Ferdinand
Postgraduate Medicine|August 12, 2009
From protocol to practice: translating the clinical data into clinical practiceKeith C Ferdinand
Obesity (Silver Spring, Md.)|August 5, 2020
Understanding African American COVID-19 Severity and Mortality: Is Obesity the Key?Keith C Ferdinand
Journal of Clinical Hypertension (Greenwich, Conn.)|September 20, 2020
Uncontrolled hypertension in sub-Saharan Africa: Now is the time to address a looming crisisKeith C Ferdinand
Journal of Clinical Hypertension (Greenwich, Conn.)|March 9, 2006
The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?Keith C Ferdinand
Ethnicity & Disease|February 22, 2005
Retrospective analysis: consensus statement of the hypertension in African Americans working group of the International Society on Hypertension in Blacks (ISHIB)Keith C Ferdinand
Cardiorenal Medicine|February 6, 2013
Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination TherapyKeith C Ferdinand
Pageof 29